Skip to content

INDIVIDUALIZED HOMOEOPATHIC MEDICINE Vs FOLLICULINUM IN PCOS

ROLE OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE Vs FOLLICULINUM IN MANAGEMENT OF POLYCYSTIC OVARIAN SYNDROME - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081030
Enrollment
60
Registered
2025-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Sponsors

Dr Soni Devi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Women between age of 18 to 35 years 2 Married & Unmarried females 3 Diagnosed cases of PCOS according to Rotterdam criteria 2003 Criteria should include two of the following three criteria Chronic anovulation Hyperandrogenism Polycystic ovaries 4 Body Mass Index BMI between 18.5 40 kg/m2 5 Participants willing to adopt healthy diet and to take regular exercise at least 30 minutes of exercise for at least 5 days a week 6 Patients with ability to give informed consent with comply with study

Exclusion criteria

Exclusion criteria: 1 Pregnant and lactating women 2 Below the age of 18 and above the age of 35 years 3 Women with other hormonal disorders example Cushing syndrome congenital adrenal hyperplasia 4 Women taking hormonal medicines Birth control pills fertility medicine 5 History of intake of drugs Aldactone/Metformin or history of oral pills OCP use or intake of drugs known to interfere with carbohydrate metabolism 4 weeks prior to enrollment 6 Cases with any systemic disease HTN DM Thyroid or any Immune Suppressive Disease 7 Patients who can not make regular follow up

Design outcomes

Primary

MeasureTime frame
To determine whether there is a significant difference between the effectiveness of Folliculinum and Individualized Homoeopathic Medicine in PCOS Management.Timepoint: 6 months

Secondary

MeasureTime frame
To access the condition of ovaries by pelvic USG and the Modified Naranjo Criteria for Homoeopathy (MONARCH) to access the likelihood of casual relationship between Homoeopathic Medicine and clinical outcome.Timepoint: 6 months

Countries

India

Contacts

Public ContactDr Soni Devi

State National Homoeopathic Medical College and Hospital Lucknow

mansisrivastava.roli@gmail.com9810150710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026